[Elsevier] Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine

adaymz Post time 2024-5-27 16:53:09 | Show all posts |Read mode
Reward10points

journal£ºJournal of the Neurological Sciences

Authors£ºTodd J. Schwedt; Tina M. Myers Oakes; James M. Martinez; Bert B. Vargas; Hitendra N. Pandey; Eric M. Pearlman; Diane R. Richardson; Oralee J. Varnado; Michael Cobas Meyer; Peter J. Goadsby

Published date£º2023-12-

DOI£º10.1016/j.jns.2023.121116

PDF link£ºhttps://www.sciencedirect.com/sc ... 022510X23005774/pdf

Article link£ºhttp://dx.doi.org/10.1016/j.jns.2023.121116

Article Source£ºElsevier BV¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Gowbe Post time 2024-5-27 16:53:10 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1430

Latest Reply

Return to the list